Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Gary A. Lyons

Viscardia, Inc


Gary A. Lyons held various positions with Neurocrine Biosciences, Inc., a biopharmaceutical company, for 16 years through January 2008, including President and Chief Executive Officer. From 1983 to 1993, Mr. Lyons held various executive positions at Genentech, Inc., a biotechnology company, including Vice President of Business Development, Vice President of Sales, and Director of Sales and Marketing. Mr. Lyons presently serves as a member of the board of directors of Neurocrine Biosciences, Inc. and Cytori Therapeutics, Inc., and is chairman of the board of directors of Rigel Pharmaceuticals, Inc. and Retrophin, Inc., all of which are publicly held biotechnology companies. In addition, Mr Lyons previously served on the boards of directors of PDL BioPharma, Facet Biotech Corporation, KaloBios Pharmaceuticals, and NeurogesX, Inc. Mr. Lyons holds a bachelor’s degree in marine biology from the University of New Hampshire and an M.B.A. degree from Northwestern University, JL Kellogg Graduate School of Management.

Research Interest


Global Experts from Cambodia

Global Experts in Subject

Share This Profile